España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Cartesian Therapeutics
RNAC
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$19.02
-0.00050
0.00%
Pre-Market: Dec 20, 4:30 PM EDT
Get Report
Comment
Cartesian Therapeutics (RNAC) Forecast
News
Earnings
Cartesian Therapeutics (RNAC) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Cartesian Therapeutics (NASDAQ:RNAC) Stock
Cartesian Therapeutics Stock (NASDAQ: RNAC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 19, 2024
BTIG Initiates Coverage On Cartesian Therapeu...
Benzinga Newsdesk
Friday, December 13, 2024
Cartesian Therapeutics Files For Proposed Res...
Benzinga Newsdesk
Cartesian Therapeutics Files For Mixed Shelf ...
Benzinga Newsdesk
Wednesday, December 04, 2024
HC Wainwright & Co. Reiterates Buy on Cartesi...
Benzinga Newsdesk
Tuesday, December 03, 2024
Cartesian Therapeutics Announced Updated Effi...
Benzinga Newsdesk
Needham Reiterates Buy on Cartesian Therapeut...
Benzinga Newsdesk
Monday, November 25, 2024
Needham Reiterates Buy on Cartesian Therapeut...
Benzinga Newsdesk
Friday, November 08, 2024
HC Wainwright & Co. Maintains Buy on Cartesia...
Benzinga Newsdesk
Needham Reiterates Buy on Cartesian Therapeut...
Benzinga Newsdesk
Wednesday, October 16, 2024
Needham Reiterates Buy on Cartesian Therapeut...
Benzinga Newsdesk
Tuesday, October 15, 2024
Cartesian Therapeutics Reports Presentation O...
Benzinga Newsdesk
Friday, September 13, 2024
HC Wainwright & Co. Reiterates Buy on Cartesi...
Benzinga Newsdesk
Monday, September 09, 2024
The FDA Has Granted Rare Pediatric Disease De...
Benzinga Newsdesk
Wednesday, September 04, 2024
HC Wainwright & Co. Reiterates Buy on Cartesi...
Benzinga Newsdesk
Tuesday, September 03, 2024
Cartesian Therapeutics Has Dosed The First Pa...
Benzinga Newsdesk
Monday, August 12, 2024
HC Wainwright & Co. Maintains Buy on Cartesia...
Benzinga Newsdesk
Friday, August 09, 2024
Needham Maintains Buy on Cartesian Therapeuti...
Benzinga Newsdesk
Thursday, August 08, 2024
Cartesian Therapeutics Cash, Cash Equivalents...
Benzinga Newsdesk
Cartesian Therapeutics Q2 2024 GAAP EPS $0.54...
Benzinga Newsdesk
Tuesday, August 06, 2024
TD Cowen Initiates Coverage On Cartesian Ther...
Benzinga Newsdesk
Monday, July 08, 2024
Needham Reiterates Buy on Cartesian Therapeut...
Benzinga Newsdesk
Friday, July 05, 2024
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Wednesday, July 03, 2024
HC Wainwright & Co. Maintains Buy on Cartesia...
Benzinga Newsdesk
Canaccord Genuity Maintains Buy on Cartesian ...
Benzinga Newsdesk
Tuesday, July 02, 2024
Oppenheimer Downgrades Cartesian Therapeutics...
Benzinga Newsdesk
Cartesian's Autoimmune Disorder Candidate Hits Primary Goal In Mid-Stage Study, Announces Equity Raise Of $130M
Vandana Singh
Cartesian Therapeutics shares are trading low...
Benzinga Newsdesk
Cartesian Therapeutics Has Entered Into A Pri...
Benzinga Newsdesk
Cartesian Therapeutics Has Dosed The First Pa...
Benzinga Newsdesk
Cartesian Therapeutics Announced Topline Resu...
Benzinga Newsdesk
Monday, July 01, 2024
Needham Reiterates Buy on Cartesian Therapeut...
Benzinga Newsdesk
Monday, June 24, 2024
Oppenheimer Reiterates Outperform on Cartesia...
Benzinga Newsdesk
Monday, June 17, 2024
HC Wainwright & Co. Reiterates Buy on Cartesi...
Benzinga Newsdesk
Friday, June 14, 2024
Oppenheimer Maintains Outperform on Cartesian...
Benzinga Newsdesk
Tuesday, June 04, 2024
Oppenheimer Initiates Coverage On Cartesian T...
Benzinga Newsdesk
Friday, May 24, 2024
Mizuho Initiates Coverage On Cartesian Therap...
Benzinga Newsdesk
Thursday, May 23, 2024
HC Wainwright & Co. Reiterates Buy on Cartesi...
Benzinga Newsdesk
Wednesday, May 22, 2024
Cartesian Therapeutics Secures FDA Regenerati...
Benzinga Newsdesk
Monday, May 13, 2024
What Makes Cartesian Therapeutics, Inc. a New Buy Stock
Zacks
Thursday, May 09, 2024
HC Wainwright & Co. Reiterates Buy on Cartesi...
Benzinga Newsdesk
Wednesday, May 08, 2024
Needham Reiterates Buy on Cartesian Therapeut...
Benzinga Newsdesk
Cartesian Therapeutics' Approximately $104.8M...
Benzinga Newsdesk
Cartesian Therapeutics Q1 2024 GAAP EPS $(10....
Benzinga Newsdesk
Tuesday, April 23, 2024
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Cartesia...
Benzinga Newsdesk
HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Cartesian Therapeutics shares are trading hig...
Benzinga Newsdesk
Leerink Partners Initiates Coverage On Cartes...
Benzinga Newsdesk
Tuesday, April 16, 2024
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Monday, April 15, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch